Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Phase 1
Recruiting
- Conditions
- Myelodysplastic SyndromesAcute Myeloid Leukemia
- Interventions
- First Posted Date
- 2023-11-24
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- GluBio Therapeutics Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06146257
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
🇺🇸University of California Irvine, Irvine, California, United States
🇺🇸University of Kansas Medical Center Research Institute, Inc., Kansas City, Kansas, United States
News
No news found